The Efficacy of Add-on Telbivudine Versus Switching to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients With Poor Responses to Adefovir

BACKGROUND: There are limited options for chronic hepatitis B (CHB) patients who have poor responses to adefovir (ADV). OBJECTIVES: The aim of this study is to evaluate the effects of adding on telbivudine (LdT) or switching to pegylated interferon alfa-2a (PEG-IFN-α2a) as alternative rescue therapi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Xin, Fan, Chao, Zhou, Yun, Kang, Wenzhen, Wang, Jiuping, Sun, Li, Wang, Linxu, Peng, Meijuan, Lian, Jianqi, Jia, Zhansheng, Hao, Chunqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834190/
https://www.ncbi.nlm.nih.gov/pubmed/27110255
http://dx.doi.org/10.5812/hepatmon.31278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834190/
https://www.ncbi.nlm.nih.gov/pubmed/27110255
http://dx.doi.org/10.5812/hepatmon.31278

Ejemplares similares